ADMA Biologics Aktie
8,31
USD
-0,11
USD
-1,31
%
8,30
USD
-0,12
USD
-1,37
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
ADMA Biologics Aktie Analyse
| 15.04.19 | ADMA Biologics Buy | H.C. Wainwright & Co. | |
| 07.02.19 | ADMA Biologics Buy | H.C. Wainwright & Co. | |
| 11.12.17 | ADMA Biologics Buy | Maxim Group | |
| 23.01.17 | ADMA Biologics Buy | Maxim Group | |
| 13.05.15 | ADMA Biologics Buy | Maxim Group | |
| 08.12.14 | ADMA Biologics Outperform | Oppenheimer & Co. Inc. | |
| 01.12.14 | ADMA Biologics Buy | Maxim Group |
Werbung
Werbung